(Q35624327)

9 August 2017

title

Solving the antidepressant efficacy question: effect sizes in major depressive disorder (English)

1 reference

major depressive disorder

9 August 2017

main subject

1 reference

Paul A Vöhringer

1

1 reference

9 August 2017

S Nassir Ghaemi

series ordinal

2

1 reference

9 August 2017

publication date

2 December 2011

1 reference

9 August 2017

published in

Clinical Therapeutics

1 reference

9 August 2017

volume

33

1 reference

9 August 2017

issue

12

1 reference

9 August 2017

page(s)

B49-61

1 reference

Maintenance treatment study designs in bipolar disorder: do they demonstrate that atypical neuroleptics (antipsychotics) are mood stabilizers?

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242920

Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242920

Placebo, prozac and PLoS: significant lessons for psychopharmacology

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242920

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242920

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242920

Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242920

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242920

Relapse into mania or depression following lithium discontinuation: a 7-year follow-up

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242920

SSRIs versus other antidepressants for depressive disorder

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242920

Is severe depression a separate indication? ECNP Consensus Meeting September 20, 1996, Amsterdam. European College of Neuropsychopharmacology

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242920

Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242920

Antidepressant drugs and the response in the placebo group: the real problem lies in our understanding of the issue

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242920

Should we treat depression with drugs or psychological interventions? A reply to Ioannidis

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242920

Differential effects of venlafaxine in the treatment of major depressive disorder according to baseline severity

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242920

Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242920

Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials?

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242920

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242920

The Carroll rating scale for depression. III. Comparison with other rating instruments

25 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22136980

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Three-year outcomes for maintenance therapies in recurrent depression

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22136980

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.CLINTHERA.2011.11.019

1 reference

9 August 2017

1 reference

9 August 2017

1 reference